公开(公告)号：US20150150867A1

公开(公告)日：2015-06-04

申请号：US14613693

申请日：2015-02-04

Applicant: H. Lundbeck A/S

Inventor： Astrid-Maria Hojer ,  Pernille Gundorf Drewes ,  Jens Kateb

IPC: A61K31/495 ,  A61K9/28 ,  A61K9/20 ,  A61K9/50

CPC classification number: A61K9/2846 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/5026 ,  A61K9/5078 ,  A61K31/495

Abstract: Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.

Abstract translation: 提供1- [2-（2,4-二甲基 - 苯硫基） - 苯基]哌嗪及其药学上可接受的酸加成盐的药物组合物，其适于在胃中不发生释放。

公开(公告)号：US20160256398A1

公开(公告)日：2016-09-08

申请号：US14886333

申请日：2015-10-19

Applicant: H. Lundbeck A/S

Inventor： Astrid-Maria Hojer ,  Pernille Gundorf Drewes ,  Jens Kateb

IPC: A61K9/28 ,  A61K31/495

CPC classification number: A61K9/2846 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/5026 ,  A61K9/5078 ,  A61K31/495

Abstract: Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.